-
Article
Open Accessm6A modification mediates SLC3A2/SLC7A5 translation in 3-methylcholanthrene-induced uroepithelial transformation
3-Methylcholanthracene (3-MC) is one of the most carcinogenic polycyclic aromatic hydrocarbons (PAHs). Long-term exposure to PAHs has been thought of as an important factor in urothelial tumorigenesis. N6-methyla...
-
Article
Superselective renal arterial embolization for severe postpercutaneous nephrolithotomy haemorrhage: clinical characteristics and risk factors for initial failure
To identify the clinical characteristics of patients who underwent superselective renal arterial embolization (SRAE) after percutaneous nephrolithotomy (PCNL) and to explore the risk factors for failed initial...
-
Article
Trends in urinary stone composition in 23,182 stone analyses from 2011 to 2019: a high-volume center study in China
To evaluate the distribution and dynamic trends in constituents of urinary stones in China.
-
Article
Is multiple tract percutaneous nephrolithotomy a safe approach for staghorn calculi?
To explore the safety of multiple tract percutaneous nephrolithotomy (PNL) in terms of complication and draw a nomogram to predict the possibility of significant renal function decline (SRFD).
-
Article
Open AccessProgrammable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development
Accumulating evidence has revealed significant roles for N6-methyladenosine (m 6 A) modification in the development of various cancers. We previously demonstrated an oncogenic role of m 6 A-modified CUB domain...
-
Article
Day-surgery percutaneous nephrolithotomy: a gap between inspiring results and the reality
-
Article
Open AccessLncRNA-miRNA-mRNA expression variation profile in the urine of calcium oxalate stone patients
To explore long-non-coding RNA (lncRNA), microRNA (miRNA) and messenger RNA (mRNA) expression profiles and their biological functions in the urine samples in calcium oxalate (CaOx) patients.
